Hair Loss Biopharma Firm Veradermics Raises $256 Million in IPO

www.bloomberg.com

Summarize this content to 100 words: Veradermics Inc., a biopharmaceutical firm focused on hair restoration, raised $256.3 million in an upsized US initial public offering priced above the top of its marketed range.



Read More